[{"id":"4ba245b3-cdd7-41e7-a5f3-8109c12962b8","acronym":"","url":"https://clinicaltrials.gov/study/NCT04977193","created_at":"2021-07-26T17:53:30.495Z","updated_at":"2024-07-02T16:36:27.467Z","phase":"Phase 1","brief_title":"A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma","source_id_and_acronym":"NCT04977193","lead_sponsor":"Shanghai Longyao Biotechnology Inc., Ltd.","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LY011"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 11/01/2021","start_date":" 11/01/2021","primary_txt":" Primary completion: 05/01/2023","primary_completion_date":" 05/01/2023","study_txt":" Completion: 11/01/2024","study_completion_date":" 11/01/2024","last_update_posted":"2021-07-26"},{"id":"e617ee9b-040b-4fd4-9b5a-793a47268767","acronym":"","url":"https://clinicaltrials.gov/study/NCT04966143","created_at":"2021-07-19T14:52:25.456Z","updated_at":"2024-07-02T16:36:27.788Z","phase":"Phase 1","brief_title":"Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer","source_id_and_acronym":"NCT04966143","lead_sponsor":"Shanghai Longyao Biotechnology Inc., Ltd.","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LY011"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/01/2021","start_date":" 08/01/2021","primary_txt":" Primary completion: 08/01/2023","primary_completion_date":" 08/01/2023","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2021-07-19"}]